http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Jun 2026 16:46:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOMERICA+INC+++++++++++++For%3A+May+29/26606443.html si-local-file:///var/storage/secattach/20260604/26606443.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOMERICA+INC+++++++++++++For%3A+May+29/26606443.html Thu, 04 Jun 2026 16:46:00 -0400 BMRA O.00043523 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOMERICA+INC+++++++++++++For%3A+May+29/26606443.html si-local-file:///var/storage/secattach/20260604/26606443.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++BIOMERICA+INC+++++++++++++For%3A+May+29/26606443.html Thu, 04 Jun 2026 16:46:00 -0400 BMRA O.00043523 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html <p>Biomerica Inc. (NASDAQ: BMRA) announced it entered into a Master Services Agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The contract carries an initial development target fee of $1.75 million to be earned across multiple Statements of Work.</p> <p>The agreement establishes a three-year term with automatic one-year renewals. Development work will be performed at Biomerica's FDA-licensed, ISO 13485-certified facility in Irvine, California. Revenue will be recognized on a milestone-completion basis as deliverables are accepted.</p> <p>Biomerica was selected following a competitive evaluation process involving multiple contract development and manufacturing organization candidates. The company stated the work will utilize http://www.streetinsider.com/Corporate+News/Biomerica+secures+%241.75+million+contract+development+agreement/26561621.html Thu, 28 May 2026 08:19:22 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Press+Releases/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html <p>IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- <strong>Biomerica, Inc.</strong> (Nasdaq: BMRA), a developer and manufacturer of diagnostic test systems and CDMO services provider, today announced it has entered into a Master Services Agreement (MSA) with a confidential life sciences company to develop proprietary in vitro diagnostic (IVD) assays. The engagement carries an initial contract development target fee of over $1.75 million, to be earned across multiple Statements of Work (SOWs) under the MSA. Biomerica was chosen following a competitive evaluation in which multiple CDMO organizations were assessed.</p> <p>The MSA establishes an initial http://www.streetinsider.com/Globe+Newswire/Biomerica+Lands+a+%241.75+Million+CDMO+Master+Services+Agreement+for+IVD+Diagnostic+Development/26561618.html Thu, 28 May 2026 08:19:00 -0400 A.06822034 A.40415565 BMRA O.00043523 O.00321472 O.20026344 http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html <p>ConsumerDirect Inc. appointed Gary Lu as chief financial officer, the Irvine, California-based company announced. Lu brings more than 20 years of financial and operational experience across public companies and high-growth organizations.</p> <p>In his new role, Lu will oversee financial operations, cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will work with the executive team and board of directors on strategic planning and growth initiatives for the subscription-based business.</p> <p>Lu most recently served as chief financial officer of Biomerica Inc. (NASDAQ: BMRA), where he managed finance, accounting, tax, treasury, investor relations, legal, human resources, and information technology functions. His experience http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html Tue, 19 May 2026 09:00:39 -0400 A.03295816 A.11888053 A.13846641 A.22847412 A.24633582 A.40415565 BMRA O.00043523 O.00321472 O.00812780 O.03212109 O.03960636 O.19958700 O.20558987 http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html <p>ConsumerDirect Inc. appointed Gary Lu as chief financial officer, the Irvine, California-based company announced. Lu brings more than 20 years of financial and operational experience across public companies and high-growth organizations.</p> <p>In his new role, Lu will oversee financial operations, cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will work with the executive team and board of directors on strategic planning and growth initiatives for the subscription-based business.</p> <p>Lu most recently served as chief financial officer of Biomerica Inc. (NASDAQ: BMRA), where he managed finance, accounting, tax, treasury, investor relations, legal, human resources, and information technology functions. His experience http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html Tue, 19 May 2026 09:00:39 -0400 A.03295816 A.11888053 A.13846641 A.22847412 A.24633582 A.40415565 BMRA O.00043523 O.00321472 O.00812780 O.03212109 O.03960636 O.19958700 O.20558987 http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html <p>ConsumerDirect Inc. appointed Gary Lu as chief financial officer, the Irvine, California-based company announced. Lu brings more than 20 years of financial and operational experience across public companies and high-growth organizations.</p> <p>In his new role, Lu will oversee financial operations, cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will work with the executive team and board of directors on strategic planning and growth initiatives for the subscription-based business.</p> <p>Lu most recently served as chief financial officer of Biomerica Inc. (NASDAQ: BMRA), where he managed finance, accounting, tax, treasury, investor relations, legal, human resources, and information technology functions. His experience http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html Tue, 19 May 2026 09:00:39 -0400 A.03295816 A.11888053 A.13846641 A.22847412 A.24633582 A.40415565 BMRA O.00043523 O.00321472 O.00812780 O.03212109 O.03960636 O.19958700 O.20558987 http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html <p>ConsumerDirect Inc. appointed Gary Lu as chief financial officer, the Irvine, California-based company announced. Lu brings more than 20 years of financial and operational experience across public companies and high-growth organizations.</p> <p>In his new role, Lu will oversee financial operations, cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will work with the executive team and board of directors on strategic planning and growth initiatives for the subscription-based business.</p> <p>Lu most recently served as chief financial officer of Biomerica Inc. (NASDAQ: BMRA), where he managed finance, accounting, tax, treasury, investor relations, legal, human resources, and information technology functions. His experience http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html Tue, 19 May 2026 09:00:39 -0400 A.03295816 A.11888053 A.13846641 A.22847412 A.24633582 A.40415565 BMRA O.00043523 O.00321472 O.00812780 O.03212109 O.03960636 O.19958700 O.20558987 http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html <p>ConsumerDirect Inc. appointed Gary Lu as chief financial officer, the Irvine, California-based company announced. Lu brings more than 20 years of financial and operational experience across public companies and high-growth organizations.</p> <p>In his new role, Lu will oversee financial operations, cash and revenue management, forecasting, financial reporting, and regulatory compliance. He will work with the executive team and board of directors on strategic planning and growth initiatives for the subscription-based business.</p> <p>Lu most recently served as chief financial officer of Biomerica Inc. (NASDAQ: BMRA), where he managed finance, accounting, tax, treasury, investor relations, legal, human resources, and information technology functions. His experience http://www.streetinsider.com/Management+Changes/ConsumerDirect+hires+Gary+Lu+as+chief+financial+officer/26518318.html Tue, 19 May 2026 09:00:39 -0400 A.03295816 A.11888053 A.13846641 A.22847412 A.24633582 A.40415565 BMRA O.00043523 O.00321472 O.00812780 O.03212109 O.03960636 O.19958700 O.20558987